Nobel Bhasin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nobel Bhasin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Manish Ranjan
Baylor College of Medicine
1 shared publication- Manish Ranjan
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, USA
1 shared publication - Manish Ranjan
Feinberg School of Medicine, Northwestern University
1 shared publication - Maysoon M. Makhlouf
Department of Biomedical Sciences, Discipline of Pharmacology, Edward Via College of Osteopathic Medicine (VCOM), 4408 Bon Aire Drive, Monroe, LA 71203, USA
1 shared publication Namrata Khurana
Baylor College of Medicine
1 shared publicationPrerna Dabral
Vitalant Research Institute
1 shared publication
Latest Publications
- 1 August 2024
- Published by Springer Nature
- p. 179-203
Significant Risk Medical Devices – Gastroenterology and Urology
- 1 August 2024
- Published by Springer Nature
- p. 179-203
Significant Risk Medical Devices – Gastroenterology and Urology
- Open Access
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers
Early cancer detection and accurate monitoring are crucial to ensure increased patient survival. Recent research has focused on developing non-invasive biomarkers to diagnose cancer early and monitor disease progression at low cost and risk. Extracellular vesicles (EVs), nanosized particles secreted into extracellular spaces by most cell types, are gaining immense popularity as novel biomarker candidates for liquid cancer biopsy, as they can transport bioactive cargo to distant sites and facilitate intercellular communications. A literature search was conducted to discuss the current approaches for EV isolation and the advances in using EV-associated proteins, miRNA, mRNA, DNA, and lipids as liquid biopsies. We discussed the advantages and challenges of using these vesicles in clinical applications. Moreover, recent advancements in machine learning as a novel tool for tumor marker discovery are also highlighted.
Open AccessTumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers
Early cancer detection and accurate monitoring are crucial to ensure increased patient survival. Recent research has focused on developing non-invasive biomarkers to diagnose cancer early and monitor disease progression at low cost and risk. Extracellular vesicles (EVs), nanosized particles secreted into extracellular spaces by most cell types, are gaining immense popularity as novel biomarker candidates for liquid cancer biopsy, as they can transport bioactive cargo to distant sites and facilitate intercellular communications. A literature search was conducted to discuss the current approaches for EV isolation and the advances in using EV-associated proteins, miRNA, mRNA, DNA, and lipids as liquid biopsies. We discussed the advantages and challenges of using these vesicles in clinical applications. Moreover, recent advancements in machine learning as a novel tool for tumor marker discovery are also highlighted.
- 1 July 2022
- Published by Springer Nature
- Vol. 2514, 85-92
Patient-Derived Xenograft Models for Studying Vascular Mimicry in Melanoma In Vivo
Tumor growth needs supply of nutrients, oxygen, and blood like the rest of the tissue, but it has been observed that tumor tissue may develop its own neovascular vessels lined with tumor cells instead of the endothelial cells. This phenomenon is referred to as vascular mimicry. Understanding vascular mimicry in melanoma is necessary for the progress of targeted therapeutic research. Patient-derived melanoma xenograft models replicate the tumor microenvironment in vivo and are more reliable in predicting patient response to therapy compared to tissue culture-based methods. This book chapter describes the patient-derived xenograft (PDX) models for studying vascular mimicry in melanoma in vivo. The chapter discusses methods for tissue collection, preimplantation processing, implantation, harvest, storage, and postharvest. Detection of vasculogenic mimicry has been described using immunohistochemical expression of markers. Key words Vasculogenic mimicry melanoma PDX models in melanoma
- 1 July 2022
- Published by Springer Nature
- Vol. 2514, 85-92
Patient-Derived Xenograft Models for Studying Vascular Mimicry in Melanoma In Vivo
Tumor growth needs supply of nutrients, oxygen, and blood like the rest of the tissue, but it has been observed that tumor tissue may develop its own neovascular vessels lined with tumor cells instead of the endothelial cells. This phenomenon is referred to as vascular mimicry. Understanding vascular mimicry in melanoma is necessary for the progress of targeted therapeutic research. Patient-derived melanoma xenograft models replicate the tumor microenvironment in vivo and are more reliable in predicting patient response to therapy compared to tissue culture-based methods. This book chapter describes the patient-derived xenograft (PDX) models for studying vascular mimicry in melanoma in vivo. The chapter discusses methods for tissue collection, preimplantation processing, implantation, harvest, storage, and postharvest. Detection of vasculogenic mimicry has been described using immunohistochemical expression of markers. Key words Vasculogenic mimicry melanoma PDX models in melanoma